The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koff, J. L.
Right arrow Articles by Nadel, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koff, J. L.
Right arrow Articles by Nadel, J. A.
The Journal of Immunology, 2006, 177: 8693-8700.
Copyright © 2006 by The American Association of Immunologists, Inc.

Pseudomonas Lipopolysaccharide Accelerates Wound Repair via Activation of a Novel Epithelial Cell Signaling Cascade1

Jonathan L. Koff*,{dagger}, Matt X. G. Shao*,{dagger}, Suil Kim*,{dagger}, Iris F. Ueki* and Jay A. Nadel2,*,{dagger},{ddagger}

* Cardiovascular Research Institute, {dagger} Department of Medicine, and {ddagger} Department of Physiology, University of California, San Francisco, San Francisco, CA 94143

The surface of the airway epithelium represents a battleground in which the host intercepts signals from pathogens and activates epithelial defenses to combat infection. Wound repair is an essential function of the airway epithelium in response to injury in chronic airway diseases, and inhaled pathogens such as Pseudomonas bacteria are implicated in the pathobiology of several of these diseases. Because epidermal growth factor receptor (EGFR) activation stimulates wound repair and because LPS activates EGFR, we hypothesized that LPS accelerates wound repair via a surface signaling cascade that causes EGFR phosphorylation. In scrape wounds of NCI-H292 human airway epithelial cells, high concentrations of LPS were toxic and decreased wound repair. However, lower concentrations of LPS accelerated wound repair. This effect was inhibited by treatment with a selective inhibitor of EGFR phosphorylation (AG 1478) and by an EGFR neutralizing Ab. Metalloprotease inhibitors and TNF-{alpha}-converting enzyme (TACE) small interfering RNA inhibited wound repair, implicating TACE. Additional studies implicated TGF-{alpha} as the active EGFR ligand cleaved by TACE during wound repair. Reactive oxygen species scavengers, NADPH oxidase inhibitors, and importantly small interfering RNA of dual oxidase 1 inhibited LPS-induced wound repair. Inhibitors of protein kinase C isoforms {alpha}beta and a TLR-4 neutralizing Ab also inhibited LPS-induced wound repair. Normal human bronchial epithelial cells responded similarly. Thus, LPS accelerates wound repair in airway epithelial cells via a novel TLR-4->protein kinase C {alpha}beta->dual oxidase 1->reactive oxygen species->TACE->TGF-{alpha}->EGFR phosphorylation pathway.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Cardiovascular Research Institute funding.

2 Address correspondence and reprint requests to Dr. Jay A. Nadel, University of California, San Francisco, 505 Parnassus Avenue, Room S-1183, San Francisco, CA 94143-0130. E-mail address: jay.nadel{at}ucsf.edu

3 Abbreviations used in this paper: EGFR, epidermal growth factor receptor; DPI, diphenyleneiodonium chloride; Duox1, dual oxidase 1; EGF, epidermal growth factor; HB-EGF, heparin-binding EGF; LDH, lactate dehydrogenase; NHBE, normal human bronchial epithelial; NMEA, NG-monoethyl-L-arginine; Nox, NADPH oxidase; nPG, n-propyl gallete; PKC, protein kinase C; ROS, reactive oxygen species; siRNA, small interfering RNA; TACE, TNF-{alpha}-converting enzyme; TAPI-1, TNF-{alpha} proteinase inhibitor-1.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. W. Boots, M. Hristova, D. I. Kasahara, G. R. M. M. Haenen, A. Bast, and A. van der Vliet
ATP-mediated Activation of the NADPH Oxidase DUOX1 Mediates Airway Epithelial Responses to Bacterial Stimuli
J. Biol. Chem., June 26, 2009; 284(26): 17858 - 17867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama
Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme
J. Immunol., June 15, 2009; 182(12): 7408 - 7414.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Luxen, D. Noack, M. Frausto, S. Davanture, B. E. Torbett, and U. G. Knaus
Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells
J. Cell Sci., April 15, 2009; 122(8): 1238 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P-R. Burgel and J. A. Nadel
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Koff, M. X. G. Shao, I. F. Ueki, and J. A. Nadel
Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1068 - L1075.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Luxen, S. A. Belinsky, and U. G. Knaus
Silencing of DUOX NADPH Oxidases by Promoter Hypermethylation in Lung Cancer
Cancer Res., February 15, 2008; 68(4): 1037 - 1045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.